Advanced Medical Solutions Group PLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Advanced Medical Solutions Group PLC
The global advanced wound-care market is expected to reach $10.4bn by 2020, driven by massive competition, and forcing companies to innovate constantly to address the rising prevalence of chronic wound injuries, diabetic foot ulcers and burns. While regulatory and reimbursement challenges prevail, opportunities in this highly segmented market, in particular, in the advanced wound-dressings sector, are vast, with double-digit revenue growth potential.
Advanced Medical Solutions is on the hunt for acquisition opportunities to grow its wound-care business following a 20% increase in revenue during the first half of 2016.
Medical device companies raised $800 million in the fourth quarter of 2011, and venture capital represented half of that amount. Just over $4 billion was spent to acquire medical device companies, down 50% from Q3’s $8 billion. In vitro diagnostics/research financings were well above the previous quarter, raking in a total of $269 million, with late-stage rounds again bringing in most of the Q4 money. Only five M&A deals were completed, totalling $915 million – way down from Q3’s $2.8 billion for the same number of deals.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
- Medical Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Surgical Equipment & Devices
- Other Names / Subsidiaries
- Advanced Medical Solutions B.V.
- MedLogic Global Ltd.
- Advanced Medical Solutions (Plymouth) Ltd.
- Biomatlante SA